U.S. Retail Distributors Stock News

NasdaqGS:RGLD
NasdaqGS:RGLDMetals and Mining

Royal Gold (RGLD) Stock Could Be 27% Undervalued On Cash Flow Strength

Royal Gold has delivered a strong share price gain over the past three years, yet the current valuation picture is more mixed, with the intrinsic value estimate based on a Discounted Cash Flow (DCF) model suggesting the stock trades at a discount while market based multiples look closer to fair value. Royal Gold has returned about 79.5% over three years, which puts more focus on whether the current price still leaves room for attractive long term returns. The company’s cash flow profile and...
NYSE:RACE
NYSE:RACEAuto

Ferrari (RACE) Stock May Be Fully Priced Despite Strong 89% Returns

Ferrari stock has delivered a strong 89.5% total return over the past 5 years, yet its current valuation screens as expensive on several checks, which raises questions about how much optimism is already built into the price. Over 5 years, Ferrari has returned 89.5%, which puts recent share price weakness over the past year into the context of a longer period of solid gains. Expectations for sustained demand in the high end luxury performance segment can support rich multiples. However, any...
NYSE:GD
NYSE:GDAerospace & Defense

General Dynamics (GD) Stock Still Looks Below Fair Value After New Contracts

General Dynamics has delivered a 116.0% return over the past 5 years, yet current valuation work suggests the stock may still trade at a discount to its intrinsic value. With fresh contract wins and recent share gains, the key issue for investors is how much of that story is already in the US$380.96 share price. The 116.0% 5 year return signals that General Dynamics has already created substantial value for shareholders, so any further upside may depend on how reliable the current cash flow...
NasdaqGS:SRPT
NasdaqGS:SRPTBiotechs

Sarepta Therapeutics (SRPT) Could Be 28% Below Fair Value As New CEO Takes Over

Sarepta Therapeutics (SRPT) is back in focus after the board appointed Michael Severino, M.D., as chief executive and director, with his tenure beginning July 28, 2026, following Douglas Ingram’s departure. See our latest analysis for Sarepta Therapeutics. Despite the leadership change and the recent shelf registration, Sarepta Therapeutics’ 1-day share price return of 0.68% comes after a year-to-date share price decline of 27.10% and a 5-year total shareholder return decline of 76.99%, which...
NasdaqGS:LBRD.K
NasdaqGS:LBRD.KMedia

Liberty Broadband (LBRD.K) Is Up 12.2% After Steep Q2 Swing To US$2.13 Billion Net Loss

Liberty Broadband Corporation has reported second-quarter 2026 results showing a net loss of US$2.13 billion, compared with net income of US$383 million a year earlier, with basic and diluted loss per share from continuing operations of US$14.86 versus earnings of US$2.49 previously. For the first half of 2026, the swing from net income of US$651 million to a net loss of US$1.92 billion, and from earnings per share of US$4.13 to a loss of US$13.44, raises questions about how such a sharp...
NasdaqGS:ICFI
NasdaqGS:ICFIProfessional Services

ICF International (ICFI) Could Be 24% Undervalued After Its AI Marketplace Win

ICF International (ICFI) is back in focus after its AI enabled DevSecOps knowledge fabric achieved “Awardable” status in the Department of War’s Platform One marketplace, supported by its CMMC Level 2 cybersecurity certification. See our latest analysis for ICF International. The recent AI enabled contract momentum comes as ICF International’s share price shows improving short term sentiment, with a 7 day share price return of 8.32% and 90 day share price return of 15.87%, while the 3 year...
NasdaqGS:MRNA
NasdaqGS:MRNABiotechs

Moderna (MRNA) Beat Revenue Views, Is The Stock Now Too Expensive?

Moderna (MRNA) has been in focus after its recent quarter showed significant year over year revenue growth that beat market expectations, along with fresh European approvals and progress in late stage pipeline programs. See our latest analysis for Moderna. Even with the recent pullback, with the 1 month share price return down 21.82% and the 7 day share price return down 6.17%, Moderna still shows strong year to date share price momentum of 76.57% and a 1 year total shareholder return of...
NYSE:MOS
NYSE:MOSChemicals

Should Political Scrutiny Of Fertilizer Pricing And Earnings Pressure Require Action From Mosaic (MOS) Investors?

Recently, US Senate candidates in Iowa and Nebraska intensified criticism of agricultural giants, spotlighting Mosaic and Nutrien’s dominant control of US phosphate and potash fertilizer production amid farmer cost pressures, prompting calls for tougher oversight of alleged market abuses. At the same time, Mosaic’s upcoming August 4 earnings release, with analysts expecting higher revenue but lower profits and a mixed track record versus estimates, has sharpened attention on how regulatory...
NYSE:MIR
NYSE:MIRElectronic

Mirion Technologies (MIR) Stock Falls As Acquisitions Mask Modest Organic Growth

Mirion Technologies stock was slightly in the red by early afternoon on Wednesday, down about 1.7% near US$14.30 after a tough three months that left shares lower by more than 25%. The market reaction looks cautious, yet the headline from this earnings print is clear. The earnings report put a spotlight on margins and cash generation, with adjusted earnings before interest, tax, depreciation and amortisation expanding and adjusted free cash flow hitting one of the strongest first half...
NasdaqGS:GOOGL
NasdaqGS:GOOGLInteractive Media and Services

Alphabet (GOOGL) Reassigns AlphaFold Team To Put Gemini First

Google DeepMind has disbanded its AlphaFold team and reassigned staff to work on the Gemini large language model and new scientific research programs. AlphaFold development is set to continue under broader DeepMind oversight rather than a dedicated team. This internal shift reflects a reallocation of talent and focus within Alphabet's AI efforts. It could influence how investors view its research priorities. Alphabet, traded as NasdaqGS:GOOGL, is reshaping its AI focus at a time when its...
NasdaqGS:SWKS
NasdaqGS:SWKSSemiconductor

Skyworks Solutions (SWKS) Stock Faces Margin Squeeze As Qorvo Debt Looms

Skyworks Solutions stock barely moved at all in regular trading, sitting near US$61 after drifting only 0.03% lower, even though the underlying story is far from flat. The company just printed Q3 revenue of about US$935 million with non GAAP earnings per share of US$1.08, both hovering above management’s own midpoint. That is the short term snapshot. The bigger story for you is profit pressure. Gross margin around 45% and operating margin near 19% sit inside a multi quarter squeeze, just as...
NYSE:WAB
NYSE:WABMachinery

Is Westinghouse Air Brake Technologies (WAB) Fully Priced Following Earnings And Its Share Buyback?

Westinghouse Air Brake Technologies (WAB) has paired its latest earnings release with a completed share buyback that together reshape the picture for investors focused on cash returns and per share performance. See our latest analysis for Westinghouse Air Brake Technologies. The latest earnings update and completed buyback come after a strong run in Westinghouse Air Brake Technologies’ share price, with a year to date share price return of 34.9% and a 1 year total shareholder return of 53.8%...
NYSE:BE
NYSE:BEElectrical

Bloom Energy (BE) Stock Jumps As First $1b Quarter Reshapes Profit Story

Bloom Energy stock is roaring higher today, up about 27% intraday, after a bruising few months for shareholders. The market is treating this as a clean reset on the story. The question is whether that surge reflects genuine earnings power or just excitement about artificial intelligence driven power demand. The headline is simple. Bloom Energy just delivered its first quarter above US$1b in revenue, with Q2 sales of US$1.065b and strong profitability to match. The market is cheering the...
NasdaqGS:MSFT
NasdaqGS:MSFTSoftware

Can Microsoft (MSFT) Justify A 41% Fair Value Gap?

Microsoft stock has pulled back over the past year, yet the current share price still sits well below where an intrinsic value estimate suggests it could be. That sets up a clear valuation question because both a Discounted Cash Flow (DCF) view and market multiples currently lean toward the shares looking inexpensive. Over the past 5 years Microsoft has returned 42.0%, which shows the stock has already rewarded patient investors despite more recent weakness. Large AI infrastructure...
NasdaqGS:MSTR
NasdaqGS:MSTRSoftware

3 Tech Stocks Built For AI Growth And Strong Free Cash Flow

Big tech just sent a mixed message on AI spending and cash generation. Microsoft surprised the market with stronger revenue and 43% growth in Azure, helped by rapid adoption of Microsoft 365 Copilot, while Meta reported a 91% plunge in free cash flow and cautious revenue guidance. For investors who care about strong free cash flow and balance sheet resilience, those numbers matter more than the headlines. This article looks at how that news relates to our High Free Cash Flow Tech Stocks...
NYSE:ENOV
NYSE:ENOVMedical Equipment

Are Enovis’ (ENOV) Sales Declines Quietly Rewriting Its Core Growth and Capital Allocation Story?

In recent months, Enovis has faced ongoing annual sales declines and weakening returns on capital, suggesting its current growth initiatives are not delivering the intended operational benefits. This erosion of previously reliable profit streams points to deeper operational challenges that may be reducing the effectiveness of the company’s business model and capital deployment. We’ll now examine how Enovis’ operational challenges and sales declines might alter the company’s previously...
NasdaqGS:QLYS
NasdaqGS:QLYSSoftware

Qualys (QLYS) Could Be 19% Overvalued Following Its AI Risk Update

Qualys (QLYS) recently announced new capabilities for its TotalAI product, expanding tools that help enterprises discover, monitor, and govern AI risk in line with emerging U.S. and EU requirements around safe AI use. See our latest analysis for Qualys. Qualys shares trade at US$135.13, with a 90 day share price return of 52.64% and a 5 year total shareholder return of 28.50%, while the 3 year total shareholder return declined 2.11%. This suggests recent momentum has picked up compared with...
NYSE:CMRE
NYSE:CMREShipping

Costamare (CMRE) Earnings Put Its Undervalued Narrative To The Test

Costamare earnings put recent share performance in context Costamare (CMRE) has just released second quarter 2026 results. This gives investors fresh data on how the containership and dry bulk operator is performing after a mixed period for the stock. The company reported Q2 revenue of US$209.19 million compared with US$217.9 million a year earlier, with net income of US$82.65 million versus US$88.69 million for the same period. See our latest analysis for Costamare. Despite the softer Q2...
NYSE:LOW
NYSE:LOWSpecialty Retail

Lowe's Companies (LOW) Could Be 18% Undervalued On August Earnings Expectations

Lowe's Companies (LOW) heads toward its August 19, 2026 earnings release with analysts expecting earnings per share to decline year over year, while quarterly revenue is projected to be higher and the stock holds a Zacks Rank #4 (Sell). See our latest analysis for Lowe's Companies. Lowe's Companies' share price of $215.68 reflects a mixed picture, with a 7 day share price return of 5.54% but a year to date share price return down 12.64%. The 1 year total shareholder return is down 3.22% and...
NYSE:HPQ
NYSE:HPQTech

HP (HPQ) Stock Looks Cheap On Cash Flow And Earnings

HP stock has delivered a strong 28.4% year to date return, while both its Discounted Cash Flow (DCF) intrinsic value estimate and market multiples currently point to the shares trading at a discount to what the underlying cash flows suggest. The 28.4% year to date gain signals that investors have already repriced HP higher. However, the valuation work still indicates room between the share price and the intrinsic value estimate. Expectations that HP can keep converting earnings into cash...
NYSE:GNRC
NYSE:GNRCElectrical

Is Generac Holdings (GNRC) Below Fair Value On 2026 Guidance And Q2 Earnings?

Generac Holdings (GNRC) drew fresh attention after maintaining its full year 2026 net sales growth guidance in the mid to high teens range, along with releasing detailed second quarter earnings figures. See our latest analysis for Generac Holdings. Generac Holdings shares trade at $195.19 after a sharp 31.23% decline in the 30 day share price return and a 24.7% decline over 90 days. However, the year to date share price return of 38.33% and 3 year total shareholder return of 68.34% suggest...
NYSE:ABT
NYSE:ABTMedical Equipment

Why Abbott (ABT) Is Up 7.4% After Mixed Q2 Results And Expanded Heart Device, Diagnostics Push

Abbott Laboratories recently reported second-quarter 2026 results showing sales rising to US$12,593 million from US$11,142 million a year earlier, while net income fell to US$928 million and diluted EPS from continuing operations slipped to US$0.53 from US$1.01. At the same time, Abbott is strengthening its medical device and diagnostics portfolio with a large real-world TriClip heart valve study and ongoing expansion in diabetes and oncology testing, which could reshape how investors view...
NasdaqGS:PCAR
NasdaqGS:PCARMachinery

PACCAR (PCAR) Stock Pullback Follows Steady Margins And Record Parts Revenue

PACCAR stock gave back 3.1% today, yet the quarter it just put up looks more like steady execution than a business hitting the brakes. The trucking giant delivered Q2 revenue of about US$7.5b with net income of US$752m, powered by strong truck demand and a record performance in its high margin Parts business. The short term reaction looks driven more by expectations and nerves than by cracks in the numbers. Coming into the print, PACCAR had climbed over the past month and quarter, which...